MDX-240: Submitted the equivalent of an IND for a Phase I/II trial

Medarex Inc. (MEDX), Princeton Product: MDX-240 Bispecific antibody combining a MAb that binds the HIV gp-41 protein, and one that attaches to the Fc receptor on immune cells Indication: HIV infectio...